Weijing Sun, MD

Sprint Professor of Medical Oncology and director of the Division of Medical Oncology

Published Articles (1)

Pancreatic Cancer: A RAS Inhibitor Nearly Doubles Survival, and a KRAS Vaccine Shows Real Promise

August 7, 2026

Pancreatic cancer has been a difficult disease to move the needle on: median survival with first-line chemotherapy has hovered around six months for decades, and targeted therapy has largely unsuccess here despite working elsewhere.